
Harvard team's decade-long quest points to lithium as a possible Alzheimer's breakthrough
A 10-year study finds lithium occurs naturally in the brain — and that its depletion may be one of the earliest signs of Alzheimer's. Now a new compound is heading for clinical trials.
When Bruce Yankner's team published their findings last August, his inbox stopped being his own.
Messages have been pouring in ever since, from people living with Alzheimer's and from the families who love them. All of them want to know the same thing: is this the breakthrough?
"I try to get back to everybody who contacts me," Yankner, a professor of genetics and neurology at Harvard Medical School, told the Harvard Gazette. "I try to provide hope."
Read full story →


